BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 29, 2000
View Archived Issues
Innovata and Vectura to develop inhaled protein and peptide drugs
Read More
FDA approves Visicol
Read More
Targeted Genetics completes acquisition of Genovo; initiates project with Biogen
Read More
New prostate cancer vaccine selected for clinical trials by Progenics, Cytogen
Read More
Variagenics and Boehringer Ingelheim join forces for pharmacogenomics program
Read More
Autoantibodies found to be associated with autoimmune autonomic neuropathy
Read More
Italian researchers report new classes of highly potent nootropic agents
Read More
Potential antiatherosclerotic agents presented in Bologna by Latvian investigators
Read More
Results of marimastat/carboplatin combination trial in ovarian cancer disappointing
Read More
New inhibitors of IMP-1 metallo-beta-lactamase tested in combination with imipenem
Read More
Two-antigen combination melanoma vaccine enters phase I/II at MGH
Read More
Theratechnologies enhances therapeutic peptide pipeline through acquisition
Read More
BioTransplant and Novartis create xenotransplantation research company
Read More
Corixa to file Melacine BLA for stage II melanoma
Read More
Cytokine grants CNI-1493 license to Axxima
Read More
Novasite awarded Phase I SBIR grant for lead molecule identification
Read More
O-Vax ovarian cancer vaccine awarded orphan drug status in U.S.
Read More
Ampligen clears first stage of regulatory review in the E.U.
Read More
AstraZeneca synthesizes new selective opioid agonist analgesics
Read More
Fujisawa discontinues development of FK-888
Read More
Sagami receives patent for apoptosis inhibitor
Read More
3-D researchers patent alphav integrin inhibitors with broad indications
Read More
Novel vitronectin receptor antagonists and their use in bone disorders patented
Read More
Sanofi-Synthelabo presents new selective NK1 receptor antagonists
Read More
University of Virginia researchers patent felbamate derivatives useful for neurological diseases
Read More
Neurological compounds disclosed by Cephalon in patent literature
Read More
New MMP inhibitors useful for multiple sclerosis, etc.
Read More
Eisai receives patent for new compounds interacting with AMPA receptors
Read More